Advanced Accelerator Applications Appoints Christine Mikail to Board of Directors
May 25, 2017 11:05 am UTC| Business
SAINT-GENIS-POUILLY, France, May 25, 2017 -- Advanced Accelerator Applications S.A. (NASDAQ:AAAP) (AAA or the Company), an international specialist in Molecular Nuclear Medicine (MNM), today announced that Christine...
Advanced Accelerator Applications Appoints Christine Mikail to Board of Directors
May 25, 2017 11:05 am UTC| Business
SAINT-GENIS-POUILLY, France, May 25, 2017 -- Advanced Accelerator Applications S.A. (NASDAQ:AAAP) (AAA or the Company), an international specialist in Molecular Nuclear Medicine (MNM), today announced that Christine...
Advanced Accelerator Applications Appoints Christine Mikail to Board of Directors
May 25, 2017 11:05 am UTC| Business
SAINT-GENIS-POUILLY, France, May 25, 2017 -- Advanced Accelerator Applications S.A. (NASDAQ:AAAP) (AAA or the Company), an international specialist in Molecular Nuclear Medicine (MNM), today announced that Christine...
Advanced Accelerator Applications Appoints Christine Mikail to Board of Directors
May 25, 2017 11:05 am UTC| Business
SAINT-GENIS-POUILLY, France, May 25, 2017 -- Advanced Accelerator Applications S.A. (NASDAQ:AAAP) (AAA or the Company), an international specialist in Molecular Nuclear Medicine (MNM), today announced that Christine...
Advanced Accelerator Applications Appoints Christine Mikail to Board of Directors
May 25, 2017 11:05 am UTC| Business
SAINT-GENIS-POUILLY, France, May 25, 2017 -- Advanced Accelerator Applications S.A. (NASDAQ:AAAP) (AAA or the Company), an international specialist in Molecular Nuclear Medicine (MNM), today announced that Christine...
Elite Pharmaceuticals’ SequestOx™ Study Results Expected in July
May 25, 2017 11:04 am UTC| Business
NORTHVALE, N.J., May 25, 2017 -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB:ELTP), today announced that top-line results for its reformulated SequestOx™ study are expected in July 2017. Patient...
Elite Pharmaceuticals’ SequestOx™ Study Results Expected in July
May 25, 2017 11:04 am UTC| Business
NORTHVALE, N.J., May 25, 2017 -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB:ELTP), today announced that top-line results for its reformulated SequestOx™ study are expected in July 2017. Patient...